| Treatment A | Treatment B |  |
---|---|---|---|
 | PP 150 mg eq. | PP 50-150 mg eq. | Total |
 | (N = 186) | (N = 26) | (N = 212) |
Age (years) | |||
Mean (SD) | 41.4 (10.24) | 35.7 (8.17) | 40.7 (10.17) |
Sex, n (%) | Â | Â | Â |
Men | 138 (74) | 16 (62) | 154 (73) |
Women | 48 (26) | 10 (38) | 58 (27) |
Race, n (%) | |||
White | 88 (47) | 8 (31) | 96 (45) |
Black | 36 (19) | 6 (23) | 42 (20) |
Asian | 60 (32) | 12 (46) | 72 (34) |
Othera | 2 (1) | 0 | 2 (< 1) |
Ethnicity, n (%) | |||
Not Hispanic or Latino | 184 (99) | 24 (92) | 208 (98) |
Hispanic or Latino | 2 (1) | 2 (8) | 4 (2) |
Weight (kg) | Â | Â | Â |
Mean (SD) | 78.1 (18.55) | 73.5 (16.45) | 77.5 (18.33) |
Height (cm) | Â | Â | Â |
Mean (SD) | 170.6 (10.24) | 171.0 (9.97) | 170.6 (10.18) |
Baseline body mass index (kg/m 2) | |||
Category, n (%) | Â | Â | Â |
Normal < 25 | 70 (38) | 14 (54) | 84 (40) |
Overweight 25- < 30 | 66 (35) | 7 (27) | 73 (34) |
Obese ≥ 30 | 50 (27) | 5 (19) | 55 (26) |
Mean (SD) | 26.71 (5.55) | 24.91 (4.16) | 26.49 (5.42) |
Psychiatric Evaluations b | Â | Â | Â |
PANSS total scores, Mean (SD) | 55.5 (8.87) | 51.5 (9.86) | 55.0 (9.08) |
PSP, Mean (SD) | 67.3 (10.41) | 68.0 (10.01) | 67.4 (10.33) |
CGI-S, Median (Range) | 3.0 (2;6) | 3.0 (2;5) | 3.0 (2;6) |